|
|
|
Volumn 24, Issue 3 SUPPL. 8, 1997, Pages
|
|
Phase II trial of gemcitabine and weekly cisplatin for advanced non- small cell lung cancer
a
a
NONE
(Canada)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
GEMCITABINE;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
RIBONUCLEOTIDE REDUCTASE;
ADULT;
ADVANCED CANCER;
AGED;
CANCER STAGING;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
ERYTHROCYTE TRANSFUSION;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
MALE;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
TREATMENT PLANNING;
ANEMIA;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG ERUPTION;
LUNG;
LUNG TUMOR;
MIDDLE AGED;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ANEMIA;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
DEOXYCYTIDINE;
DRUG ADMINISTRATION SCHEDULE;
DRUG ERUPTIONS;
FEMALE;
HUMANS;
LUNG;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEUTROPENIA;
RIBONUCLEOTIDE REDUCTASES;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
|
|
EID: 0030919967
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (62)
|
|
References (19)
|
